Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021) Hirohiko ShibayamaMitsuhiro ItagakiShinsuke Iida Original Article Open access 29 March 2024 Pages: 707 - 721
Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain Hirono IriuchishimaAkio SaitoMorio Matsumoto Original Article 29 March 2024
A prospective study of zanubrutinib, a Bruton tyrosine kinase inhibitor, in relapsed/refractory idiopathic multicentric Castleman disease Lu ZhangYu-han GaoJian Li Original Article 28 March 2024 Pages: 631 - 637
Allogeneic hematopoietic stem cell transplantation after mogamulizumab in T-cell lymphoma patients: a retrospective analysis Mary Jo LechowiczChristy SmithKaren Dwyer Original Article Open access 27 March 2024 Pages: 736 - 744
Hereditary TTP/Upshaw–Schulman syndrome: the ductus arteriosus controls newborn survival Yoshihiro Fujimura Review Article 27 March 2024 Pages: 532 - 540
Recent advances in understanding the biology of follicular lymphoma Momoko Nishikori Progress in Hematology 27 March 2024
Rapamycin increases leukemia cell sensitivity to chemotherapy by regulating mTORC1 pathway-mediated apoptosis and autophagy Jing XuSiwen ZongZhenjiang Li Original Article 26 March 2024 Pages: 541 - 551
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia Kensuke UsukiToshihiro MiyamotoThe Study Group for NS-87/CPX-351 Original Article Open access 26 March 2024 Pages: 647 - 659
Vitamin B12 deficiency-induced megaloblastic anemia in a pediatric patient with autism spectrum disorder with a chronically unbalanced diet Yuri SawadaKenichi SakamotoChihiro Sawai Case Report 25 March 2024 Pages: 613 - 616
Sustained remission after cord blood transplantation for breast cancer with lung metastases and myelodysplastic syndrome Naokazu NakamuraNao YamamotoNobuyoshi Arima Case Report 25 March 2024 Pages: 762 - 767
Aortitis after switching short-acting granulocyte colony-stimulating factors in a lymphoma patient with HLA-B52 Misato TaneHideki KosakoTakashi Sonoki Case Report 23 March 2024 Pages: 608 - 612
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan Akira KawasakiKiyohiko HatakeKensei Tobinai Original Article Open access 23 March 2024 Pages: 667 - 676
Platelet and large platelet ratios are useful in predicting severity of COVID-19 Hisae SugiharaAtsushi MarumoEriko Morishita Original Article 23 March 2024 Pages: 638 - 646
End-of-treatment 18[F]-FDG PET can predict early progression in patients receiving bendamustine-rituximab for follicular lymphoma in first relapse: a prospective West Japan hematology Study Group (W-JHS) NHL01 trial Koji KatoKoji IzutsuJunji Suzumiya Original Article 22 March 2024 Pages: 677 - 685
Effect of apolipoprotein E (APOE) gene polymorphisms on the lipid profile of children being treated for acute lymphoblastic leukemia Maria IoannidouChrysostomos AvgerosEmmanuel Hatzipantelis Original Article Open access 20 March 2024 Pages: 755 - 761
Early hematopoietic cell transplantation for familial hemophagocytic lymphohistiocytosis in a regional treatment network in Japan Masataka IshimuraKatsuhide EguchiShouichi Ohga Original Article 20 March 2024 Pages: 592 - 602
Incidence trends for common subtypes of T-cell lymphoma in Taiwan and the United States from 2008–2020 Chung-I HuangChien-Yu KerYu-Chieh Su Original Article 17 March 2024 Pages: 728 - 735
Evaluation of the pathogenic potential of germline DDX41 variants in hematopoietic neoplasms using the ACMG/AMP guidelines Hirotaka MatsuiMakoto Hirata Original Article 16 March 2024 Pages: 552 - 563
Prognostic model for relapsed/refractory transplant-ineligible diffuse large B-cell lymphoma utilizing the lymphocyte-to-monocyte ratio Daisuke IdeTakahiro FujinoJunya Kuroda Original Article 16 March 2024 Pages: 697 - 706
Characteristics of chronic lymphocytic leukemia in Japan: Comprehensive analysis of the CLLRSG-01 study Jun TakizawaRitsuro SuzukiJunji Suzumiya Original Article 16 March 2024 Pages: 686 - 696
Isolated salivary gland extramedullary relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia during blinatumomab treatment Yugo KawakamiMasaru ImamuraChihaya Imai Images in Hematology 16 March 2024 Pages: 479 - 480
A case of Bloom syndrome manifesting with therapy-related myelodysplastic syndromes harboring a novel BLM gene variant Takuma OhashiHiroyoshi KunimotoHideaki Nakajima Case Report 15 March 2024 Pages: 603 - 607
JSH practical guidelines for hematological malignancies, 2023: I. Leukemia-1. Acute myeloid leukemia (AML) Yoshinobu Maeda Guideline 14 March 2024 Pages: 347 - 373
Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study Hirozumi SanoKeitaro FukushimaDaisuke Tomizawa Original Article 09 March 2024 Pages: 745 - 754
Prevalence of chromosome 8p11.2 translocations and correlation with myeloid and lymphoid neoplasms associated with FGFR1 abnormalities in a consecutive cohort from nine institutions in Japan Kensuke UsukiTakuro KamedaKazuya Shimoda Original Article Open access 08 March 2024 Pages: 722 - 727
Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study Norio KomatsuKojo AritaKoji Hanaki Correction Open access 06 March 2024 Pages: 472 - 472
Numerous osteoclasts and osteoblasts in the bone marrow due to hyperparathyroidism Yi FengTao Wang Images in Hematology 06 March 2024 Pages: 345 - 346
Characteristics and literature review of ETV6::ABL1 fusion gene-positive acute myeloid leukemia Song XueHui-Peng SunXing-Yu Cao Original Article 05 March 2024 Pages: 564 - 572
Decade-long WT1-specific CTLs induced by WT1 peptide vaccination Tatsuya SuwabeYasuhiko ShibasakiMasayoshi Masuko Original Article 01 March 2024 Pages: 399 - 406
First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants Yuka ShiozawaShinya FujitaTakaaki Toyama Case Report 29 February 2024 Pages: 465 - 471
Predictive factors for l-asparaginase hypersensitivity in pediatric acute lymphoblastic leukemia Chane Choed-AmphaiJiraporn KhoranaPimlak Charoenkwan Original Article 29 February 2024 Pages: 442 - 449
The pathogenesis of cancer-associated thrombosis Kohei Tatsumi Progress in Hematology 29 February 2024 Pages: 495 - 504
Influence of FOXP3 single-nucleotide polymorphism after allogeneic hematopoietic stem cell transplantation Kai KuroiwaMisuzu SatoNorimichi Hattori Original Article 28 February 2024 Pages: 583 - 591
Prevalence of thalassemia-carrier couples and fertility risk assessment Liu-Song WuXi LuoYan Chen Original Article 27 February 2024 Pages: 374 - 382
Long-term lymphocyte subset number reconstitution is unique but comparable between umbilical cord blood and unrelated bone marrow transplantation Keiko TsumitaShinsuke TakagiYukako Koike Original Article 26 February 2024 Pages: 573 - 582
Effects of human herpesvirus 6B reactivation on cognitive function in cord blood transplant recipients: a prospective multicenter study Masao OgataKumi OshimaMasatoshi Inagaki Original Article Open access 26 February 2024 Pages: 432 - 441
Progress in medical therapy in aplastic anemia: why it took so long? Phillip Scheinberg Progress in Hematology 26 February 2024 Pages: 248 - 254
Risk factors and remaining challenges in the treatment of acute promyelocytic leukemia Yasuhisa Yokoyama Progress in Hematology 22 February 2024
Measurement of serum hepcidin-25 by latex agglutination in healthy volunteers and patients with hematologic disorders Hiroshi KawabataNaoki MiyazawaMichio Sasa Original Article 19 February 2024 Pages: 392 - 398
Correlation of ex vivo and in vivo ammonia production with L-asparaginase biological activity in adults with lymphoid malignancies Takayuki NakamuraShuki OyaKoji Nagafuji Original Article 16 February 2024 Pages: 426 - 431
Chimeric antigen receptor T-cell therapy after COVID-19 in refractory high-grade B-cell lymphoma Kenta HayashinoKeisuke SeikeYoshinobu Maeda Case Report Open access 13 February 2024 Pages: 459 - 464
Dysregulated hemostasis in acute promyelocytic leukemia Yohei Hisada Progress in Hematology 11 February 2024 Pages: 526 - 531
Age-related variation in coagulation factors in non-valvular atrial fibrillation patients receiving direct oral anticoagulants Osamu KumanoShinya SuzukiFor the Japanese Study Group for the Assessment of Direct Oral Anticoagulants Original Article 09 February 2024 Pages: 407 - 415
Cancer-associated thrombosis and bleeding Takayuki Ikezoe Progress in Hematology 04 February 2024 Pages: 493 - 494
Aplastic anemia: history and recent developments in diagnosis and treatment Yasushi Onishi Progress in Hematology 04 February 2024 Pages: 217 - 219
Nelarabine-containing salvage therapy and conditioning regimen in transplants for pediatric T-cell acute lymphoblastic leukemia and lymphoma Masato YanagiMakiko MoriKatsuyoshi Koh Original Article 01 February 2024 Pages: 327 - 333
Histiocytic sarcoma following CAR T-cell therapy: a case report Kang AnYan HeBenshang Li Case Report 31 January 2024 Pages: 338 - 341
Diffuse large B-cell lymphoma of the skull vault Satoshi IchikawaHisayuki YokoyamaHideo Harigae Images in Hematology 30 January 2024 Pages: 215 - 216
STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment Alexandre BenoitMadelyn J. AbrahamKoren K. Mann Original Article Open access 29 January 2024 Pages: 275 - 290
TBI, etoposide, and cyclophosphamide conditioning for intermediate-risk relapsed childhood acute lymphoblastic leukemia Hideaki UekiChitose OgawaHidemi Toyoda Original Article 25 January 2024 Pages: 450 - 458
